Advertisement

Related Videos

Varsha Gandhi, PhD, on Ibrutinib

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Welcome and Introduction to Vi3C

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Advertisement

Advertisement




Feb
12
Today In Oncology
ASCO and Conexiant Launch ASCO AI in Oncology
Demographic and Clinicopathologic Factors in Colorectal Adenoma Recurrence Risk
ASH Publishes Clinical Guidelines on AL Amyloidosis Diagnosis
FDA Approves TTFields Device for Pancreatic Cancer
Interval Cancer Rate With AI-Supported Mammography Screening
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo